Danish Gunhild Waldemar starts 2022 with a new job as president for the Biomedical Alliance in Europe, which is an umbrella organization for 36 European medical societies, the group announces in a post on Linkedin.
The Biomedical Alliance in Europe was founded in 2010 to join strengths across a number of different life science areas, unifying a voice to influence decision-makers, industry professionals and the public.
"I am very honored to serve as President of the Biomedical Alliance in Europe 2022-2023 – and to contribute to the advancement of health research on behalf of our member organizations," Waldemar says in a comment to the post.
Waldemar is also the chair of the Danish Dementia Research Center and professor of Clinical Neurology at Danish hospital Righshospitalet. She has been on the board of Biomedical Alliance of Europe since 2016, and she is also a board member of the Lundbeck Foundation.
Big investments in Danish life science industry make 2021 historic year for raising capital
More from MedWatch
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Leo Pharma eczema treatment recommended in two UK countries
After postponing the decision in April, the British medicines council NICE has now ruled that Adtralza can be recommended to treat atopic dermatitis.
Fujifilm invests USD 1.5bn in Danish factory
Japanese firm Fujifilm Diosynth Biotechnologies is investing DKK 11bn (USD 1.5bn) in its factor in Northern Zealand, Denmark. The expansion will provide 450 jobs.
Life science firms are planning USD 6.3bn construction spree in Denmark
Fujifilm’s expansion to its factory in Hillerød means that the life science sector has announced DKK 12bn (USD 1.7bn) in facility investments in Denmark since May.
Sanofi reduces US insulin prices for the uninsured
While bills to introduce a price cap on insulin are being discussed in the US Senate, Sanofi has beaten them to the punch and reduced the price of insulin products for US diabetes patients without insurance.
Senior Manager/Associate Director, Global Regulatory Affairs, CMC 
Principal Scientist – Pharmacology 
Senior Toxicologist 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Regulatory Affairs Manager - Maternity Cover 
Scientific Writer 
Medical Advisor 
Global Product Manager - Pulmonology 
KLIFO is looking for a Project Director for our office in Denmark or Germany or Sweden 
Director Regulatory Affairs 
Chair of the Board 
Project Managers keep all of us healthy 
Corporate Quality Compliance Specialist for Audit Management